Chinese and Indian investors may establish drug production in Crimea

5 January 2015

A group of Indian investors will build a plant for the production of drugs in Crimea, according to Sergey Aksenov, Prime Minister of the Crimea, the former Ukrainian territory annexed by Russia last February, who said that such an agreement was reached during a December visit of Russia’s President Vladimir Putin to India.

Sergey Aksenov explained that the names of investors as well as details of future investment projects are currently not disclosed, which is mainly due to sanctions, imposed on Crimea by the USA and the European Union, reports The Pharma Letter’s local correspondent.

Mr Aksenov commented: “We are currently unable to disclose the names of investors, as much is being done through the affiliates in order to avoid sanctions.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical